Published 13 days ago

Largest Chronic Inflammatory Demyelinating Polyneuropathy Trial Offers Promising Results for Drug Combo

Summary by mdedge.com

Nearly 70% of patients showed improvement after treatment with efgartigimod plus rHuPH20 in phase 2 of the largest randomized controlled trial for CIDP to date.

0 Articles

All

Left

Center

Right

mdedge.com

Largest Chronic Inflammatory Demyelinating Polyneuropathy Trial Offers Promising Results for Drug Combo

Nearly 70% of patients showed improvement after treatment with efgartigimod plus rHuPH20 in phase 2 of the largest randomized controlled trial for CIDP to date.

13 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated12 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Largest Chronic Inflammatory Demyelinating Polyneuropathy Trial Offers Promising Results for Drug Combo

0 Articles

0 Articles

Largest Chronic Inflammatory Demyelinating Polyneuropathy Trial Offers Promising Results for Drug Combo

Largest Chronic Inflammatory Demyelinating Polyneuropathy Trial Offers Promising Results for Drug Combo

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics